Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Microencapsul ; 41(4): 284-295, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38686964

ABSTRACT

This work aimed to investigate the effectiveness of Lippia sidoides and Syzygium aromaticum essential oils (EOs) encapsulated in nanostructured lipid carriers (NLCs) as SARS-CoV-2 inhibitors through virucidal activity assessment. We developed anionic and cationic NLCs loaded with the EOs and assessed their physicochemical properties and SARS-CoV-2 virucidal activity, focusing on the effects of EO type and the NLCs composition. The NLCs exhibited particle sizes of 141.30 to 160.53 nm for anionic and 109.30 to 138.60 nm for cationic types, with PDIs between 0.16 and 0.25. High zeta potentials (>29.0 in modulus) indicated stable formulations. The NLCs effectively encapsulated the EOs, achieving encapsulation efficiencies between 84.6 to 100% w/w of marker compound. The EOs-loaded NLCs reduced the SARS-CoV-2 virion count, exceeding 2 logs over the control. NLCs loaded with Lippia sidoides and Syzygium aromaticum EOs represent an innovative strategy for combating SARS-CoV-2.


Subject(s)
Antiviral Agents , Drug Carriers , Lipids , Nanostructures , Oils, Volatile , SARS-CoV-2 , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Oils, Volatile/administration & dosage , SARS-CoV-2/drug effects , Antiviral Agents/pharmacology , Antiviral Agents/administration & dosage , Antiviral Agents/chemistry , Lipids/chemistry , Drug Carriers/chemistry , Nanostructures/chemistry , Humans , Lippia/chemistry , Syzygium/chemistry , COVID-19 Drug Treatment , Particle Size , Chlorocebus aethiops , Vero Cells , Animals , COVID-19
2.
FASEB J ; 15(3): 556-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11259365

ABSTRACT

c-Fos, a transcription factor that constitutes DNA-binding AP-1 complexes, regulates gene expression that promotes long-lasting cellular changes. We show that, in addition to its transcription factor activity, c-Fos regulates the metabolism of phospholipids cytoplasmically by an AP-1-independent activity. Two waves of c-Fos expression that promote subsequent waves of stimulation of 32P-orthophosphate incorporation into phospholipids are evidenced in quiescent cultured fibroblasts induced to re-enter the cell cycle. The first wave of c-Fos expression peaks at 7.5 min and returns to control levels by 15 min. The second wave starts by 30 min and remains elevated at 120 min. In the first wave, the lipids that incorporate 32P are predominantly second-messenger polyphosphoinositides (PIP, PIP2, PIP3); whereas in the second wave, membrane-biogenesis-related lipids (PI, PE, PA), become radioactive. Both waves of phospholipid activation depend on c-Fos expression. It is interesting that a peptide that blocks AP-1 nuclear import does not affect phospholipid activation. Immunocytochemical examination showed c-Fos immunoreactivity associated to the endoplasmic reticulum. We conclude that c-Fos, rapidly induced upon cell stimulation, associates to the endoplasmic reticulum where it first regulates the synthesis/ replenishment of phospholipids required for signal transduction pathways and subsequently regulates enzymes involved in the genesis of new membrane necessary for cell growth.


Subject(s)
Endoplasmic Reticulum/metabolism , Phospholipids/metabolism , Proto-Oncogene Proteins c-fos/metabolism , 3T3 Cells , Active Transport, Cell Nucleus , Animals , Cell Nucleus/metabolism , Endoplasmic Reticulum/chemistry , Genes, fos , Immunohistochemistry , Mice , Models, Biological , Nuclear Localization Signals/metabolism , Phospholipids/biosynthesis , Proto-Oncogene Proteins c-fos/antagonists & inhibitors , Proto-Oncogene Proteins c-fos/genetics , RNA, Antisense/metabolism , RNA, Antisense/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Time Factors , Transcription Factor AP-1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...